⭐Next Webinar Session TOMORROW, Wednesday, May 28, 06:00 PM - 07:00 PM Eastern Time Zone⭐ From Idea to Drug Approval: A Peek Behind the Curtain In this session we will learn how new amyloidosis medications come to market and ultimately get prescribed to patients like you. Kevin Freiert is a seasoned drug developer and business leader with a focus on patient-centered care and empowering patients to shape the future of medicine. He's known for his expertise in drug development, change management, and knowledge management, and he's the founder of Salem Oaks. He also hosts two podcasts, Raising Rare and Raising Improbable Developments. To Register: https://bit.ly/42Xd7c6 Zoom Meeting ID: 858 1649 2115 *These sessions cannot be recorded due to patient involvement and HIPAA laws. REGISTER HERE: https://pcc.oneamyloidosisvoice.com/amyloidosis-event-calendar/?_gl=1*1s56k00*_ga*MTUyMTEyNzUxNS4xNzIyMzYzOTY1*_ga_K7GD6SKHXM*MTcyMjQzODgzNS4zLjAuMTcyMjQzODgzNi41OS4wLjA (fb)

In this webinar sponsored by Lilly, the Foundation for Peripheral Neuropathy is pleased to welcome guest speaker Jennifer Gewandter, PhD, MPH from the University of Rochester. In this program, patients will gain a basic understanding of different phases of clinical research. Participants will also learn about potential roles for people living with neuropathy in research and important things to consider before joining a clinical trial. A live Q&A will conclude the program. Thursday, June 12 12:30 - 1:30 p.m. Eastern Time 11:30 a.m. - 12:30 p.m. Central Time 10:30 - 11:30 a.m. Mountain Time 9:30 - 10:30 a.m. Pacific Time Don't see your time zone? Try this time zone converter. Can't attend live? Register to get the recording link sent to you via email after the program, or watch for it on our website. REGISTER HERE: https://register.gotowebinar.com/register/7712309254369771606?blm_aid=8870069324 (fb)